Predictive value of lymphoscintigraphy in patients with breast cancer-related lymphedema undergoing complex decongestive therapy
Authors:
- 12 November 2018
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 173 (3) , 735-741
Abstract
We evaluated the prognostic value of lymphoscintigraphy after complex decongestive therapy (CDT) in breast cancer-related secondary lymphedema.Keywords
This publication has 17 references indexed in Scilit:
- Prevention and Management of Lymphedema after Breast Cancer TreatmentThe Breast Journal, 2015
- Validity of Quantitative Lymphoscintigraphy as a Lymphedema Assessment Tool for Patients With Breast CancerAnnals of Rehabilitation Medicine, 2015
- Limb Differences in the Therapeutic Effects of Complex Decongestive Therapy on Edema, Quality of Life, and Satisfaction in Lymphedema PatientsAnnals of Rehabilitation Medicine, 2015
- Lymphedema following breast cancer treatment and impact on quality of life: A reviewCritical Reviews in Oncology/Hematology, 2014
- Prognostic value of lymphoscintigraphy in patients with gynecological cancer‐related lymphedemaJournal of Surgical Oncology, 2014
- Ultrasonographic Evaluation of Therapeutic Effects of Complex Decongestive Therapy in Breast Cancer-Related LymphedemaAnnals of Rehabilitation Medicine, 2013
- Primary Lymphedema: Clinical Features and Management in 138 Pediatric PatientsPlastic and Reconstructive Surgery, 2011
- Upper extremity impairments in women with or without lymphedema following breast cancer treatmentJournal of Cancer Survivorship, 2010
- Lymphedema and Quality of Life in Breast Cancer Survivors: The Iowa Women's Health StudyJournal of Clinical Oncology, 2008
- Lymphedema: A Comprehensive ReviewAnnals of Plastic Surgery, 2008